Weiss Multi-Strategy Advisers’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-20,000	Closed	-$1.53M	–	536
2017 Q2	$1.53M	Buy	20,000 +3,000	+18%	+$252K	0.06%	324
2017 Q1	$1.47M	Hold	17,000	–	–	0.06%	337
2016 Q4	$1.09M	Buy	17,000 +4,000	+31%	+$246K	0.05%	272
2016 Q3	$841K	Buy	13,000 +4,252	+49%	+$240K	0.05%	305
2016 Q2	$485K	Sell	8,748 -5,752	-40%	-$289K	0.04%	325
2016 Q1	$606K	Hold	14,500	–	–	0.03%	376
2015 Q4	$912K	Sell	14,500 -6,000	-29%	-$307K	0.06%	250
2015 Q3	$835K	Buy	20,500 +500	+3%	+$28.8K	0.04%	279
2015 Q2	$1.03M	Buy	+20,000	New	+$1.06M	0.04%	317

Other funds holding LKFT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LKFT Position: Q3 2017 in Review

Weiss Multi-Strategy Advisers sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2017, closing a stake of 20,000 shares — an estimated $1.53M sold.

Weiss Multi-Strategy Advisers first reported a position in LKFT in Q2 2015 and held it in 9 quarters. The position peaked at $1.53M in Q2 2017. 69 funds tracked by Wall St. Rank hold LKFT as of Q3 2017.

Weiss Multi-Strategy Advisers reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2017 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 20,000 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2017, an estimated $1.53M.
Weiss Multi-Strategy Advisers first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 9 quarters.
Weiss Multi-Strategy Advisers's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.53M in Q2 2017.
69 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2017.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2017, filed 14 Nov 2017.